Trial Profile
A 24-Week Open-Label Study Evaluating the Efficacy and Safety of OPN-375 186 μg Twice a Day (BID) in Adults With Bilateral Nasal Polyps Using Nasoendoscopic Video
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Aug 2020
Price :
$35
*
At a glance
- Drugs Fluticasone propionate (Primary)
- Indications Nasal polyps
- Focus Therapeutic Use
- Sponsors OptiNose
- 04 Aug 2020 According to an OptiNose media release, results from this trial were published in Rhinology 2, the official journal of the International Rhinologic Society.
- 03 Jul 2019 Status changed from active, no longer recruiting to completed.
- 26 Apr 2019 Planned End Date changed from 30 Apr 2019 to 30 May 2019.